The University of Texas System Board of Regents today named Ronald A. DePinho, M.D., as the sole finalist for the presidency of MD Anderson Cancer Center.
The board announced the decision during a meeting in which candidates were interviewed for the post. Each candidate recently met several constituent groups within the cancer center's community as part of a series of campus visits.
DePinho is the director of the Belfer Institute for Applied Cancer Science at the Dana-Farber Cancer Institute and professor of medicine (genetics) at Harvard Medical School. DePinho, a member of the Institute of Medicine of the National Academies and fellow of the American Academy of Arts and Sciences, previously held numerous faculty positions at the Albert Einstein College of Medicine in New York.
Read the full news release from The University of Texas System
He received a bachelor's degree in biological sciences from Fordham College and his medical degree with distinction in microbiology and immunology from the Albert Einstein College of Medicine. DePinho's research interest is in the genetic aspects of cancer and the translation of such knowledge into clinical endpoints. He has authored hundreds of articles in peer-reviewed scientific journals.
"Dr. DePinho is a distinguished scientist and proven administrator capable of leading the nation's premiere comprehensive cancer center, UT MD Anderson. He has an excellent background in teaching and research and a demonstrated ability to work effectively within complex medical institutions," Regents' Chairman Gene Powell said. "The board is extremely confident he has the ability to advance the institution's mission "to make cancer history," Powell added.